Literature DB >> 16442887

Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot: a review.

Thomas Oosterhof1, Barbara J M Mulder, Hubert W Vliegen, Albert de Roos.   

Abstract

Cardiovascular magnetic resonance (CMR) is becoming an important tool in the clinical management of patients with congenital heart disease. Because of the diverse problems patients may face after initial correction for tetralogy of Fallot and the large amount of CMR techniques that can be applied, creating a patient-orientated imaging protocol is a difficult issue. Although it is still not certain what the impact of some parameters, provided by CMR, should be on clinical decision making, new techniques are being developed and applied. In this report, we review the current clinical issues in patients with tetralogy of Fallot and review the current implication and limitations of CMR in this patient category.

Entities:  

Mesh：

Year:  2006        PMID： 16442887     DOI： 10.1016/j.ahj.2005.03.058

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


  16 in total

1.  Multicenter review: role of cardiovascular magnetic resonance in diagnostic evaluation, pre-procedural planning and follow-up for patients with congenital heart disease.

Authors:  Nicolò Schicchi; Aurelio Secinaro; Giuseppe Muscogiuri; Paolo Ciliberti; Benedetta Leonardi; Teresa Santangelo; Carmela Napolitano; Giacomo Agliata; Maria Chiara Basile; Francesca Guidi; Paolo Tomà; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2015-12-11       Impact factor: 3.469

2.  Cardiovascular magnetic resonance in a pregnant patient with absent pulmonary valve syndrome.

Authors:  Thomas Oosterhof; Joris W J Vriend; Anje M Spijkerboer; Barbara J M Mulder
Journal:  Int J Cardiovasc Imaging       Date:  2006-09-14       Impact factor: 2.357

3.  Percutaneous pulmonary valve replacement: a new development in the lifetime strategy for patients with congenital heart disease.

Authors:  B J M Mulder; R J de Winter; A A M Wilde
Journal:  Neth Heart J       Date:  2007-01       Impact factor: 2.380

4.  Tetralogy of Fallot: in good shape?

Authors:  Barbara J M Mulder; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-16       Impact factor: 2.357

5.  Diastolic dysfunction: a new additional criterion for optimal timing of pulmonary valve replacement in adult patient with tetralogy of Fallot?

Authors:  Barbara J M Mulder; Hubert W Vliegen; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-24       Impact factor: 2.357

6.  Signal intensity enhances diagnostic capacity in myocardial infarction.

Authors:  A van der Laarse; E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2009-03-17       Impact factor: 2.357

7.  Duchenne muscular dystrophy; a cardiomyopathy that can be prevented?

Authors:  Barbara J M Mulder; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-10-01       Impact factor: 2.357

8.  Effects of pulmonary regurgitation on distensibility and flow of the branch pulmonary arteries in tetralogy of Fallot.

Authors:  Eva M Voser; Christian J Kellenberger; Emanuela R Valsangiacomo Buechel
Journal:  Pediatr Cardiol       Date:  2013-01-06       Impact factor: 1.655

9.  Role and effectiveness of cardiovascular magnetic resonance in the diagnosis, preoperative evaluation and follow-up of patients with congenital heart diseases.

Authors:  L Lovato; A Giardini; C La Palombara; V Russo; V Gostoli; G Gargiulo; F M Picchio; R Fattori
Journal:  Radiol Med       Date:  2007-07-23       Impact factor: 6.313

10.  4D cardiovascular magnetic resonance velocity mapping of alterations of right heart flow patterns and main pulmonary artery hemodynamics in tetralogy of Fallot.

Authors:  Christopher J François; Shardha Srinivasan; Mark L Schiebler; Scott B Reeder; Eric Niespodzany; Benjamin R Landgraf; Oliver Wieben; Alex Frydrychowicz
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-07       Impact factor: 5.364
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.